Table 3 Unadjusted and adjusted hazards for composite event outcome by PTH change group (quartile) for all patients and stratified by baseline PTH
Composite event * | ||||
|---|---|---|---|---|
PTH change group | Unadjusted | Adjusted | ||
All patients | HR (95% CI) | P | HR (95% CI) | P |
No PTH reduction | 1.07 (0.90-1.26) | 0.5 | 1.11 (0.94-1.32) | 0.2 |
Quartile 1 | Referent | Referent | ||
Quartile 2 | 1.04 (0.87-1.26) | 0.7 | 1.01 (0.84-1.22) | 0.9 |
Quartile 3 | 1.07 (0.89-1.29) | 0.5 | 0.98 (0.81-1.18) | 0.8 |
Quartile 4 | 1.09 (0.91-1.31) | 0.4 | 0.96 (0.79-1.16) | 0.6 |
Baseline PTH 300-600 pg/mL | ||||
No PTH reduction | 1.10 (0.86-1.42) | 0.5 | 1.14 (0.88-1.47) | 0.3 |
Quartile 1 | Referent | Referent | ||
Quartile 2 | 1.13 (0.86-1.50) | 0.4 | 1.10 (0.83-1.46) | 0.5 |
Quartile 3 | 1.03 (0.77-1.37) | 0.8 | 0.91 (0.68-1.22) | 0.5 |
Quartile 4 | 1.13 (0.85-1.49) | 0.4 | 0.98 (0.73-1.31) | 0.9 |
Baseline PTH > 600 pg/mL | ||||
No PTH reduction | 1.06 (0.85-1.34) | 0.6 | 1.08 (0.86-1.37) | 0.5 |
Quartile 1 | Referent | Referent | ||
Quartile 2 | 0.98 (0.77-1.26) | 0.9 | 0.96 (0.75-1.24) | 0.8 |
Quartile 3 | 1.12 (0.88-1.42) | 0.4 | 1.0 (0.78-1.28) | 1.0 |
Quartile 4 | 1.06 (0.84-1.35) | 0.6 | 0.93 (0.73-1.20) | 0.6 |